logo
Select company
Select metric
$ -0.18EBITDA per Share
VS
Market
30
Sector
69
Industry
86
History
38
$ 1.65Close
$ 0.39 - $ 1.81 52-Week Range
Ticker Information

Ticker

LCTX

Company Name

LINEAGE CELL THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

LINEAGE CELL THERAPEUTICS INC - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LCTX - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ -40.28M$ -0.181228.36M
3/31/2025$ -15.61M$ -0.071226.05M
12/31/2024$ -18M$ -0.091200.19M
9/30/2024$ -19.48M$ -0.11188.84M
6/30/2024$ -23.52M$ -0.121188.81M
3/31/2024$ -22.96M$ -0.131182.91M
12/31/2023$ -22.6M$ -0.131172.66M
9/30/2023$ -23.74M$ -0.141174.87M
6/30/2023$ -22.52M$ -0.131170.59M
3/31/2023$ -24.1M$ -0.141170.13M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LINEAGE CELL THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -0.16.
  • Over the past 5 years, LINEAGE CELL THERAPEUTICS INC's average EBITDAPS has been $ -0.15.
  • The median EBITDAPS for LINEAGE CELL THERAPEUTICS INC during this period was $ -0.13
  • LINEAGE CELL THERAPEUTICS INC reached its highest EBITDAPS over the past 5 years at $ -0.07.
  • The lowest EBITDAPS recorded by LINEAGE CELL THERAPEUTICS INC in the same timeframe $ -0.29

LINEAGE CELL THERAPEUTICS INC's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
TVRD : TVARDI THERAPEUTICS INC $ -1.63CRBU : CARIBOU BIOSCIENCES INC $ -1.69SRZN : SURROZEN INC $ -3.73PRTA : PROTHENA CORP PUBLIC LTD CO $ -4.79FATE : FATE THERAPEUTICS INC $ -1.31KRRO : KORRO BIO INC $ -9.09CAPR : CAPRICOR THERAPEUTICS INC $ -1.5TNXP : TONIX PHARMACEUTICALS HOLDING CORP $ -10.84OCGN : OCUGEN INC $ -0.17CRVO : CERVOMED INC $ -2.53

Similar metrics to Shares WA:

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for LINEAGE CELL THERAPEUTICS INC is calculated as follows: EBITDA [ $ -23.89M ] / (Shares WA [ 149.97M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -0.16 ]

LCTX - EBITDA per Share, Last 5 years

$ -0.29

Minimum

Jun 30, 2022

$ -0.07

Maximum

Mar 31, 2025

$ -0.15

Average

$ -0.13

Median

EBITDAPS Benchmark Analysis

 The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.01 with a standard deviation of $ 4.26.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -10.86
max$ 13.95
average$ 2.01
median$ 0.99
std$ 4.26